148 related articles for article (PubMed ID: 181108)
1. Studies on the effect of nicotinamide and ethylnicotinic acid on cyclic AMP phosphodiesterase from rat liver.
Hoshi Y
Bull Osaka Med Sch; 1975 Oct; 21(2):77-91. PubMed ID: 181108
[No Abstract] [Full Text] [Related]
2. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.
Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y
Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by nicotinic acid [proceedings].
Saeed SA; Butt NM; Lovely JR; Collier HO
Biochem Soc Trans; 1979 Oct; 7(5):1042-4. PubMed ID: 229022
[No Abstract] [Full Text] [Related]
4. Metabolism of adenosine-3', 5'-cyclic monophosphate in the liver of rats treated with nicotinamide.
Lusini P; Ricci C
Ital J Biochem; 1983; 32(3):152-60. PubMed ID: 6317608
[TBL] [Abstract][Full Text] [Related]
5. [Effect of thyroxine on the contents of cyclic AMP and on the activity of cyclic AMP phosphodiesterase in hepatocytes of the rat].
Leoni S; Spagnuolo S
Boll Soc Ital Biol Sper; 1975 Dec; 51(23):1874-8. PubMed ID: 182190
[No Abstract] [Full Text] [Related]
6. Possible participation of glucocorticoid in elevation of 3',5'-cyclic AMP levels through inhibition of cyclic AMP phosphodiesterase.
Tanigawa Y; Kitamura A; Kawamura M; Shimoyama M; Fujii K; Kohri Y; Ueda I
Physiol Chem Phys; 1978; 10(5):443-8. PubMed ID: 220644
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase 4 regulation of cyclic AMP in pulmonary remodelling: potential roles for isoform selective inhibitors.
Shepherd MC
Pulm Pharmacol Ther; 2006; 19(1):24-31. PubMed ID: 16046159
[No Abstract] [Full Text] [Related]
8. Induction of motility in immature bovine spermatozoa by cyclic AMP phosphodiesterase inhibitors and seminal plasma.
Hoskins DD; Hall ML; Munsterman D
Biol Reprod; 1975 Sep; 13(2):168-76. PubMed ID: 177102
[No Abstract] [Full Text] [Related]
9. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries.
Birk S; Edvinsson L; Olesen J; Kruuse C
Eur J Pharmacol; 2004 Apr; 489(1-2):93-100. PubMed ID: 15063160
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of psoralens on rat liver cyclic AMP phosphodiesterase.
Bovalini L; Lusini P; Simoni S; Vedaldi D; Andreassi L; Dall'Acqua F; Martelli P
Biochem Int; 1988 Jun; 16(6):991-8. PubMed ID: 2845992
[TBL] [Abstract][Full Text] [Related]
11. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.
Schwabe U; Miyake M; Ohga Y; Daly JW
Mol Pharmacol; 1976 Nov; 12(6):900-10. PubMed ID: 187926
[No Abstract] [Full Text] [Related]
12. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
13. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
Kass DA
Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
[No Abstract] [Full Text] [Related]
14. Endogenous protein inhibitor of mitochondrial c-AMP phosphodiesterase in tumour bearing rats.
Sankaran K
Indian J Biochem Biophys; 1986 Apr; 23(2):66-9. PubMed ID: 3021610
[No Abstract] [Full Text] [Related]
15. New substituted triaza-benzo[cd]azulen-9-ones as promising phosphodiesterase-4 inhibitors.
Devillers I; Pevet I; Jacobelli H; Durand C; Fasquelle V; Puaud J; Gaudillière B; Idrissi M; Moreau F; Wrigglesworth R
Bioorg Med Chem Lett; 2004 Jun; 14(12):3303-6. PubMed ID: 15149695
[No Abstract] [Full Text] [Related]
16. [Interaction between cyclic adenosine-3':5'-monophosphate phosphodiesterase and structural analogs of the substrate].
Kochetkova MN; Guliaev NN; Tunitskaia VL; Severin ES
Biokhimiia; 1981 Feb; 46(2):353-60. PubMed ID: 6264977
[TBL] [Abstract][Full Text] [Related]
17. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF
J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810
[TBL] [Abstract][Full Text] [Related]
18. [Adenosine cyclic-3',5'-monophosphate phosphodiesterase in hepatomas with different growth rates].
Pavlova VM; Bogdanov GN; Vatolkina OE; Libinzon RE
Eksp Onkol; 1984; 6(4):28-30. PubMed ID: 6094146
[TBL] [Abstract][Full Text] [Related]
19. Insulin controls intracellular cyclic AMP concentrations in hepatocytes by activating specific cyclic AMP phosphodiesterases: phosphorylation of the peripheral plasma membrane enzyme.
Houslay MD; Wallace AV; Marchmont RJ; Martin BR; Heyworth CM
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():159-76. PubMed ID: 6326521
[No Abstract] [Full Text] [Related]
20. Activation of rat parotid low Km cyclic AMP phosphodiesterase by isoproterenol.
Teo TS; Lee MK; Thiyagarajah P
Biochem Int; 1987 Feb; 14(2):327-36. PubMed ID: 3034281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
